Catalogo dei prodotti della ricerca

PAPA, ANSELMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.168
EU - Europa 586
AS - Asia 405
SA - Sud America 16
AF - Africa 11
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.146
IT - Italia 189
SE - Svezia 166
SG - Singapore 141
CN - Cina 121
IN - India 119
FI - Finlandia 63
DE - Germania 38
GB - Regno Unito 23
FR - Francia 22
CA - Canada 19
UA - Ucraina 19
RO - Romania 16
IE - Irlanda 15
BE - Belgio 8
ID - Indonesia 7
AR - Argentina 6
CL - Cile 6
JP - Giappone 6
RU - Federazione Russa 5
TG - Togo 5
AT - Austria 4
BG - Bulgaria 4
ZA - Sudafrica 4
NL - Olanda 3
BR - Brasile 2
EG - Egitto 2
HR - Croazia 2
LV - Lettonia 2
TH - Thailandia 2
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
TM - Turkmenistan 1
TR - Turchia 1
VN - Vietnam 1
Totale 3.189
Salva come PNG Salva come JPEG
Città #
Fairfield 348
Ashburn 230
Chandler 171
Woodbridge 151
Seattle 132
Houston 114
Cambridge 113
Wilmington 111
Singapore 103
Beijing 82
Ann Arbor 71
Princeton 58
San Paolo di Civitate 56
Plano 55
Santa Clara 47
Lawrence 36
Millbury 32
Rome 32
Boston 26
San Diego 18
Andover 17
Dublin 15
Norwalk 15
Ottawa 12
Helsinki 10
Bühl 9
Washington 9
Brussels 8
Dearborn 8
Des Moines 8
Phoenix 8
Redwood City 8
Dallas 7
Fremont 7
Jakarta 7
Toronto 7
Boardman 6
Cagliari 6
Federal 6
Southend 6
Hefei 5
Lomé 5
Pune 5
Florence 4
Frankfurt am Main 4
Grafing 4
Kunming 4
Los Angeles 4
Moscow 4
Mumbai 4
San Mateo 4
Sofia 4
Bangalore 3
Bremen 3
Falkenstein 3
Hamadacho 3
Jacksonville 3
London 3
Muizenberg 3
Nanjing 3
New York 3
Tokyo 3
Vienna 3
Cairo 2
Cortona 2
Gunzenhausen 2
Indiana 2
Jinan 2
Jinhua 2
Leawood 2
Mountain View 2
Nanchang 2
Newark 2
Palermo 2
Paris 2
Porto Sant'Elpidio 2
Recife 2
Riga 2
Rozzano 2
San Michele All'adige 2
Santiago Metropolitan 2
Zagreb 2
Zhengzhou 2
Albano Laziale 1
Ashgabat 1
Auckland 1
Bangkok 1
Bari 1
Brno 1
Cernobbio 1
Chengdu 1
Chicago 1
Chiswick 1
Civitavecchia 1
Colombo 1
Crocetta del Montello 1
Dhaka 1
Dolianova 1
Dossenheim 1
Edinburgh 1
Totale 2.306
Salva come PNG Salva come JPEG
Nome #
Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation 119
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) 118
Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report 100
INfluenza vaccine indication during therapy with Immune checkpoint inhibitors: a transversal challenge. the INVIDIa study 96
G-CSF related bone pain (BP) and Bv8/PK2 expression: Is there a link in breast cancer (BC) patients (pts) treated with FEC100 adjuvant chemotherapy (CT)? 87
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment 87
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study. 85
Current approach in the treatment of hepatocellular carcinoma. 84
Breast cancer risk after ovarian stimulation for In vitro fertilization 84
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 83
Niraparib in ovarian cancer. results to date and clinical potential 81
Triple-negative breast cancer: investigating potential molecular therapeutic target 78
Triple negative breast cancer: new perspectives for targeted therapies 76
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study 75
Angiogenesis and antiangiogenic agents in cervical cancer 71
Correlation between fertility drugs use and malignant melanoma incidence: the state of the art 71
Fertility drugs, reproductive strategies and ovarian cancer risk 70
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis 69
Quality of life effects of ovarian suppression in the suppression of ovarian function trial 67
Fertility drugs and breast cancer risk 67
Cerebral metastases in patients with left atrial myxoma 65
Profilo delle cellule tumorali staminali di colangiocarcinoma in situ, in vitro ed in circolo: correlati clinico-patologici e prognostici 63
Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. 63
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 61
Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer. 61
Current status of bevacizumab in advanced ovarian cancer 60
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 58
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: Basic knowledge and therapeutic possibilities for an innovative approach 58
An unusual case of spleen metastasis from carcinoma ex pleomorphic adenoma of the parotid gland 55
null 55
Chemotherapy and Target Therapy in the Management of Adult High-Grade Gliomas 54
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 53
Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma 52
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 49
null 48
null 45
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer 44
Plerixafor and autologous stem cell transplantation: Impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy 40
Emerging Role of Cetuximab in the Treatment of Colorectal Cancer 39
Innovations in the treatment of ovarian cancer. Analysis of the therapeutic development: from platinum to immunotherapy [Innovazioni terapeutiche nel trattamento del tumore ovarico. Analisi del percorso per lo sviluppo terapeutico: dal platino all’immunoterapia] 38
Correlation between bmi and chemotherapy related amenorrhea (cra) in premenopausal breast cancer patients (pbcp) 38
From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors 36
null 33
null 33
Efficacia degli inibitori delle aromatasi nel trattamento del carcinoma della mammella in stadio precoce 33
Correlation between BMI and chemotherapy related amenorrhea (CRA) in premenopausal breast cancer (PBC) patients treated with adjuvant anthracycline-cyclophosphamide (AC) and docetaxel (T) 32
L78 ROLE OF PEGFILGASTIM (P) AND LENOGASTIM (L) IN PATIENTS WITH NON-METASTATIC BREAST CANCER RECEIVING ADJUVANT FEC 100 CHEMOTHERAPY 32
Lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer patients (nmbcp) 31
Incidence of amenorrhea in premenopausal women with breast cancer (BC) undergoing chemotherapy (CT) with antracyclines (A), cyclophosfamide (C) and docetaxel (D) 31
null 29
INCIDENCE OF ANTRACYCLINE CARDIOTOXICITY IN BREAST CANCER WOMEN: A RETROSPECTIVE ANALYSIS OF 6 YEARS CLINICAL PRACTICE 27
Abstract 1437: Relationship of G-CSF related bone pain (BP) with Bv8/PK2 expression in breast cancer (BC) patients (pts) treated with FEC100 adjuvant chemotherapy (CT) 27
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 25
L70 MANAGEMENT OF NEUTROPENIA: EFFICACY AND SAFETY OF LENOGASTIM (L) AND PEGFILGASTIM (P) IN NON-METASTATIC BREAST CANCER PATIENTS TREATED WITH FEC 100 PLUS DOCETAX 24
Bevacizumab in ovarian cancer: A critical review of phase III studies 23
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 23
Targeting angiogenesis in endometrial cancer - New agents for tailored treatments 21
null 20
Radiological and pathological complete response in a young patient locally advanced her2 breast cancer after neoadjuvant treatment with trastuzumab and non-pegylated liposomal doxorubicin (nPLD) 20
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 19
null 18
The role of body mass index (bmi) on chemotherapy related amenorrhea (cra) in premenopausal breast cancer (bc) patients treated with adjuvant anthracycline , cyclophosphamide (ac) and taxane (t) 17
null 15
Non pegylated liposomal doxorubicin (npld) in neoadjuvant treatment of local advanced breast cancer (labc) 14
Totale 3.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020517 0 0 0 0 0 82 91 86 98 72 55 33
2020/2021239 27 27 11 14 15 46 3 16 25 31 19 5
2021/2022587 5 20 68 30 80 16 16 57 44 35 102 114
2022/2023643 131 180 43 29 70 69 15 32 52 0 18 4
2023/2024319 28 46 22 17 44 63 3 20 6 28 19 23
2024/2025238 13 16 63 34 78 34 0 0 0 0 0 0
Totale 3.350